Multicenter analysis reveals no survival advantage of complete lymph node dissection in melanoma patients with positive sentinel lymph node biopsy, indicating a need for reevaluation of treatment...
In patients with melanoma and positive high-risk SLNB, CLND does not appear to confer a significant survival benefit or prevent locoregional recurrence.
No takes yet. Share an insight, caveat, or question.
Samaniego-González et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: